RE:RE:News: Positive Preclinical Toxicology Results
The presentation will include safety and efficacy results of the new skin lightener TFC-1067, the glycoprotein program for anti-aging and regenerative medicine, as well as updates from the SGLT2 inhibitor program that is currently under license agreement with Wanbang Biopharmaceuticals
So we will have news about TFC-1067 and anti-aging soon.